Erythropoietin receptor is detectable on peripheral blood lymphocytes and its expression increases in activated T lymphocytes

Haematologica

Volumn 96, Issue 3, 2011, Pages 13-

  Lisowska, Katarzyna A ^a   Bryl, Ewa ^a   Witkowski, Jacek M ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Erythropoietin; Lymphocytes; Receptors

Indexed keywords

ERYTHROPOIETIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; CD3 ANTIGEN; PHYCOERYTHRIN;

ANEMIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHRONIC KIDNEY FAILURE; CYTOKINE RELEASE; DRUG MECHANISM; HEMODIALYSIS PATIENT; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; LETTER; LYMPHOCYTE ACTIVATION; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; T LYMPHOCYTE; BIOSYNTHESIS; CD4 LYMPHOCYTE COUNT; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FLUORESCENCE; IMMUNOLOGY; METABOLISM; NOTE;

ANTIBODIES; ANTIGENS, CD3; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ERYTHROPOIETIN, RECOMBINANT; FLUORESCENCE; HUMANS; IMMUNOMODULATION; KIDNEY FAILURE, CHRONIC; LYMPHOCYTE ACTIVATION; PHYCOERYTHRIN; RECEPTORS, ERYTHROPOIETIN;

EID: 79952327334     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.038414     Document Type: Letter

References (7)

1. Lifshitz L, Tabak G, Mittelman M, Gassmann M, Neumann D. Macrophages as novel targets for erythropoietin. Haematologica. 2010;95(11):1823-40.
2. Prutchi-Sagiv S, Golishevsky N, Oster HS, Katz O, Cohen A, Naparstek E, et al. Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease? Br J Haematol. 2006;135(5):660-72.
3. Sela S, Shurtz-Swirski R, Sharon R, Manaster J, Chezar J, Shkolnik G, et al. The polymorphonuclear leukocyte--a new target for erythropoietin. Nephron. 2001;88(3):205-10.
4. Bryl E, Mysliwska J, Debska-Slizien A, Trzonkowski P, Rachon D, Bullo B, et al. Recombinant human erythropoietin stimulates production of interleukin 2 by whole blood cell cultures of hemodialysis patients. Artif Organs. 1999;23(9):809-16.
5. Bryl E, Mysliwska J, Debska-Slizien A, Rachon D, Bullo B, Lizakowski S, et al. The influence of recombinant human erythropoietin on tumor necrosis factor alpha and interleukin-10 production by whole blood cell cultures in hemodialysis patients. Artif Organs. 1998;22(3):177-81.
6. Lisowska KA, Debska-Slizien A, Radzka M, Witkowski JM, Rutkowski B, Bryl E. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes. Artif Organs. 2010;34(3):E77-84.
7. Lisowska KA, Debska-Slizien A, Bryl E, Rutkowski B, Witkowski JM. Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Artif Organs. 2010;34(8):654-62.